Probiotics and trace elements for ulcerative colitis
Part of Digestive system clinical trials.
This trial tests whether adding a probiotic supplement and trace elements to your current treatment helps manage mild to moderate ulcerative colitis. It aims to see if these additions can improve symptoms and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with mild to moderate ulcerative colitis.
- You are currently on a biologic therapy (like infliximab) for your ulcerative colitis.
- You have not taken probiotics or trace elements in the past month.
- You do not have other serious health conditions like autoimmune diseases, liver cirrhosis, chronic kidney disease, or colorectal cancer.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a specially designed supplement that aims to restore healthy gut bacteria in people with mild-to-moderate ulcerative colitis. The goal is to reduce inflammation and improve symptoms like rectal bleeding and bowel urgency.
This study tests a new way to monitor ulcerative colitis using stool tests and colonoscopy to detect early signs of cancer. It may help doctors manage long-term ulcerative colitis more safely.
This study uses breath tests to see how a special diet changes gases in your gut that might affect ulcerative colitis. It aims to find out if these changes can help manage your condition.
This study tests an investigational drug called LIV001 for people with mild-to-moderate ulcerative colitis. It aims to see if the drug is safe and may help reduce inflammation in the colon.
This trial tests a live bacteria powder (SK08) taken by mouth for ulcerative colitis. It aims to see if the bacteria can reduce inflammation and improve symptoms. You may qualify if standard treatments haven't worked well for you.
This trial tests an oral study drug called Hemay005 for people with moderate to severe ulcerative colitis (UC) who have not responded well to other treatments. If you join, you will receive either the study drug or a placebo (inactive pill) to see if it helps reduce symptoms and heal the gut lining.
Hear when a new Ulcerative Colitis (UC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.